Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease.
First proof for rituximab in IgG4-related disease
Treatment of neuromyelitis optica.
Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
The role of T cell apoptosis in nervous system autoimmunity.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Application of fullerenes in nanomedicine: an update.
Analysis: Healthy babies born after accelerated elimination of teriflunomide
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab.
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice.
Idebenone for primary progressive multiple sclerosis
BTG Commences Phase IIa Study of Multiple Sclerosis
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
Mountain View Pharmaceuticals receives European patent on potential long-acting drug for multiple sclerosis
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
[The Sjögren's syndrome and multiple sclerosis: similarity and differences.]

Pages